Shares of NovaBay Pharmaceuticals Inc. (NBY) are surging over 42% in pre-market today, after the company announced testing results from an independent third-party laboratory confirming that Avenova, NovaBay's proprietary formulation of pure hypochlorous acid, kills SARS-CoV-2.
from RTT - Before the Bell https://ift.tt/3gULUf6
via IFTTT
No comments:
Post a Comment